Our latest blog post highlights how a pair of trailblazing scientists have reshaped the landscape of vaccine science through mRNA technology, as well as the critical role of intellectual property (IP) in facilitating innovation. It's a testament to how strategic investment in research and development, underpinned by IP, meets global patient needs.